ginecología y obstetricia
Inyecciones anticonceptivas de progestágenos
Referencias
1.Fotherby K, Howard G: Return of fertility in women discontinuing injectable contraceptives.J Obstet Gynaecol (Lahore)6 Suppl 2:S110-S115, 1986. doi:10.3109/01443618609081724 2.Westhoff C, Truman C, Kalmuss D, et al: Depressive symptoms and Depo-Provera.Contraception57(4):237-240, 1998. doi:10.1016/s0010-7824(98)00024-9 3.Singata-Madliki M, Carayon-Lefebvre d'Hellencourt F, Lawrie TA, et al: Effects of three contraceptive methods on depression and sexual function: An ancillary study of the ECHO randomized trial.Int J Gynaecol Obstet154(2):256-262, 2021. doi:10.1002/ijgo.13594 4.Gupta N, O'Brien R, Jacobsen LJ, et al: Mood changes in adolescents using depot-medroxyprogesteroneacetate for contraception: a prospective study.J Pediatr Adolesc Gynecol14(2):71-76, 2001. doi:10.1016/s1083-3188(01)00074-2 5.Lawrie TA, Hofmeyr GJ, De Jager M, et al: A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones.Br J Obstet Gynaecol105(10):1082-1090, 1998. doi:10.1111/j.1471-0528.1998.tb09940.x 6.Kaunitz AM, Miller PD, Rice VM, et al: Bone mineral density in women aged 25-35 years receiving depotmedroxyprogesteroneacetate: recovery following discontinuation.Contraception74(2):90-99, 2006. doi:10.1016/j.contraception.2006.03.010 7.Rosenberg L, Zhang Y, Constant D, et al: Bone status after cessation of use of injectable progestin contraceptives.Contraception76(6):425-431, 2007. doi:10.1016/j.contraception.2007.08.010 8.Berenson AB, Rahman M, Wilkinson G: Effect of injectable and oral contraceptives on serum lipids.Obstet Gynecol114(4):786-794, 2009. doi:10.1097/AOG.0b013e3181b76bea 